Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Surprising Variability in Tryptamine Profiles of Psilocybe cubensis Fruiting Bodies: Inter- and Intra-Strain Differences Across 14 Strains Cultivated Under Controlled ConditionsJournal of Fungi · 2026-07-01Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARASAIMSARA Journal · 2026-06-14Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-08Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depressionJournal of Affective Disorders · 2026-06-03Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-28Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-06PDE4B Inhibition and Psilocybin as Promising Approaches for Treating Methamphetamine Use Disorder: Preclinical Evidence From Rat Models (Abstract ID: 232554)Journal of Pharmacology and Experimental Therapeutics · 2026-04-30SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH modelsJournal of Hepatology · 2026-04-30Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis VolatilomeChemBioChem · 2026-03-31Pilot study of psilocybin in patients with post-treatment lyme diseaseScientific Reports · 2026-02-24The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative ReviewCureus · 2026-01-30Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain ExposureJournal of Medicinal Chemistry · 2026-01-25Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-19The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysisBMC Psychology · 2026-01-01COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDERGenetics and Molecular Research · 2025-12-31Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxietyGeneral Hospital Psychiatry · 2025-12-08Acute Kidney Failure and Myocarditis Triggered by Magic Mushroom Toxicity in a Patient With Prior Cocaine ExposureCureus · 2025-11-11The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female MiceJournal of Neuroscience · 2025-11-09Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.Unknown journal · 2025-11-06Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot studyActa Neuropsychiatrica · 2025-11-03Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic reviewBJPsych Open · 2025-10-31Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trialPilot and Feasibility Studies · 2025-10-27Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric DisordersJournal of Pharma Insights and Research. · 2025-10-04An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.Unknown journal · 2025-07-24“I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smokeAddiction Science & Clinical Practice · 2025-07-20Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge studyComprehensive Psychiatry · 2025-07-01Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot studyJournal of Affective Disorders · 2025-06-08Music and non-music approaches in psilocybin-assisted psychotherapy: The sound of silenceJournal of Psychedelic Studies · 2025-05-14Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe MetabolomeChemBioChem · 2025-05-02FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLDJournal of Hepatology · 2025-04-30166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-08Psilocybin Dispensaries and Online Health Claims in CanadaJAMA Network Open · 2025-03-31Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver DiseaseDigestive and Liver Disease · 2025-01-31Oregon’s Emerging Psilocybin Services Workforce: An Environmental ScanDrug and Alcohol Dependence · 2025-01-31Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’Cureus · 2025-01-28Additional file 1 of “I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smokeFigshare · 2024-12-31Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical TrialAmerican Journal of Psychiatry · 2024-12-31Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administrationUNC Libraries · 2024-10-21Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot studyJournal of Affective Disorders · 2024-09-26Insights into the efficacy of psilocybin in treating depression and other disordersBritish Journal of Neuroscience Nursing · 2024-08-01Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy ParticipantsPsychiatric Research and Clinical Practice · 2024-07-22Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapyScientific Reports · 2024-07-16Prevalence of Psilocybin and Cannabis Concurrent Use During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-06-30High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-06-30Developing Core Consensus Measures for Assessment of Psilocybin ServicesDrug and Alcohol Dependence · 2024-06-30Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi studyJournal of Psychopharmacology · 2024-06-17THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.govDrug Design Development and Therapy · 2024-03-31Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-01-31Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.Unknown journal · 2024-01-19Psilocybe cubensis extract potently prevents fear memory recall and freezing behavior in short- but not long-term in a rat model of posttraumatic stress disorder.Behavioral Neuroscience · 2024-01-17Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsFrontiers in Psychiatry · 2024-01-08Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2023-12-31CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivityHeadache The Journal of Head and Face Pain · 2023-12-31Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorderCancer · 2023-12-17Exploring Psilocybe spp. mycelium and fruiting body chemistry for potential therapeutic compoundsFrontiers in Fungal Biology · 2023-11-28Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal surveyFrontiers in Psychiatry · 2023-09-18Long term efficacy of psilocybin in patients with cancer and major depressive disorder (MDD).Journal of Clinical Oncology · 2023-05-31New Pharmacologic Approaches to the Treatment of Bipolar Depression.Unknown journal · 2023-05-24Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J miceNeuroscience Applied · 2022-12-31Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patientsJournal of Affective Disorders · 2022-12-09Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndromePsychopharmacology · 2022-12-04Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.Contemporary Clinical Trials · 2022-11-01Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.BJPsych Open · 2022-09-05The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.Journal of Clinical Oncology · 2022-05-31The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of Psychopharmacology · 2022-01-03P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature reviewEuropean Neuropsychopharmacology · 2021-11-30Magic mushroom: all is not as it seems.Acta chirurgica Belgica · 2021-09-30Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence.Spirituality in Clinical Practice · 2021-08-31Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.Journal of Psychopharmacology · 2021-06-29Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia NervosaOBM Neurobiology · 2021-06-23Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.Experimental and Clinical Psychopharmacology · 2021-06-06Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.ACS Pharmacology & Translational Science · 2021-03-17Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in Psychiatry · 2021-02-02Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.Journal of Psychopharmacology · 2021-01-08Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humansJournal of Psychopharmacology · 2020-10-07A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor bindingEuropean Neuropsychopharmacology · 2020-03-03Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancerJournal of Psychopharmacology · 2020-01-08Psilocybin's effects on the brain and implications for depression treatmentEpubl LTU · 2019-12-31Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frameJournal of Contextual Behavioral Science · 2019-11-04Psilocybin for depression: Considerations for clinical trial designJournal of Psychedelic Studies · 2019-08-31Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levelsNeuropsychopharmacology · 2019-01-25Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.Frontiers in Pharmacology · 2018-04-02Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.Frontiers in Pharmacology · 2018-02-19Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related DistressJournal of Humanistic Psychology · 2017-06-13Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological AnalysisJournal of Humanistic Psychology · 2017-04-27Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.Journal of Psychopharmacology · 2016-11-30A new behavior change program using psilocybin.Psychotherapy · 1964-12-31